Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Psoriatic Arthritis Treatment Market: By Drug Class: NSAIDs, DMARDs, Biologics, Other; By Product Type: Prescription, OTC; By Route of Administration: Topical, Oral, Injectable; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Psoriatic Arthritis Treatment Market Outlook
The global psoriatic arthritis treatment market attained a value at USD 8.4 billion in 2020 and is further expected to grow at a CAGR of 9.8% over the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is estimated that psoriasis affects more than 125 million individuals around the globe, and psoriasis tends to create psoriatic arthritis in 30% of the population. The global industry for psoriatic arthritis treatment is influenced by an increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis.
Market Segmentation
Psoriatic arthritis is a chronic psoriasis-related degenerative disorder. Swollen fingers, toes, and tender joints, stiffness, lowered back pain, and pitted nails are prevalent symptoms of psoriatic arthritis. Psoriatic arthritis treatment market can be divided on the basis of segments like drug class, product type and administration route.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of its drug class, the market can be widely categorised as:
- NSAIDs
- DMARDs
- Biologics
- Other
Based on its product type, the market can be bifurcated as prescription and OTC.
The different administration route available for psoriatic arthritis treatment are topical, oral and injectable.
The EMR report looks into the regional psoriatic arthritis treatment markets like the North America, Latin America, Europe, Middle East and Africa, and Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is driving the global psoriatic arthritis treatment industry. The other factors aiding in the growth of the industry are investments by major companies in clinical R&D, new product launches, increasing disease prevalence and proactive government initiatives. The factors such as high cost of treatment, stringent regulatory approval and adverse effect of drugs may hinder the growth of the market in coming future.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global psoriatic arthritis treatment industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- AbbVie Inc.
- Amgen, Inc.
- Johnson & Johnson Services, Inc.
- Bristol-Myers Squibb Company
- Celgene Corporation
- Novartis International AG
- Eli Lilly and Company
- Pfizer, Inc.
- UCB S.A
- AstraZeneca plc
- Others
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Product Type, Route of Administration, Region |
| Breakup by Drug Class | NSAIDs, DMARDs, Biologics, Other |
| Breakup by Product Type | Prescription, OTC |
| Breakup by Administration | Topical, Oral, Injectable |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | AbbVie Inc., Amgen, Inc., Johnson & Johnson Services, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer, Inc., UCB S.A, AstraZeneca plc, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Psoriatic Arthritis Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Psoriatic Arthritis Treatment Historical Market (2018-2022)
8.3 Global Psoriatic Arthritis Treatment Market Forecast (2023-2028)
8.4 Global Psoriatic Arthritis Treatment Market by Drug Class
8.4.1 NSAIDs
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 DMARDs
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Biologics
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Others
8.5 Global Psoriatic Arthritis Treatment Market by Product Type
8.5.1 Prescription
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 OTC
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.6 Global Psoriatic Arthritis Treatment Market by Route of Administration
8.6.1 Topical
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Oral
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Injectable
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.7 Global Psoriatic Arthritis Treatment Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2018-2022)
9.5.2 Forecast Trend (2023-2028)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 AbbVie Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Amgen Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Johnson & Johnson Services, Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Bristol-Myers Squibb Company
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Novartis AG
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Eli Lilly and Company
12.2.6.1 Company Overview
12.2.6.2 Product Portfolio
12.2.6.3 Demographic Reach and Achievements
12.2.6.4 Certifications
12.2.7 Pfizer Inc.
12.2.7.1 Company Overview
12.2.7.2 Product Portfolio
12.2.7.3 Demographic Reach and Achievements
12.2.7.4 Certifications
12.2.8 UCB S.A.
12.2.8.1 Company Overview
12.2.8.2 Product Portfolio
12.2.8.3 Demographic Reach and Achievements
12.2.8.4 Certifications
12.2.9 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Psoriatic Arthritis Treatment Market: Key Industry Highlights, 2018 and 2028
2. Global Psoriatic Arthritis Treatment Historical Market: Breakup by Drug Class (USD Million), 2018-2022
3. Global Psoriatic Arthritis Treatment Market Forecast: Breakup by Drug Class (USD Million), 2023-2028
4. Global Psoriatic Arthritis Treatment Historical Market: Breakup by Product Type (USD Million), 2018-2022
5. Global Psoriatic Arthritis Treatment Market Forecast: Breakup by Product Type (USD Million), 2023-2028
6. Global Psoriatic Arthritis Treatment Historical Market: Breakup by Route of Administration (USD Million), 2018-2022
7. Global Psoriatic Arthritis Treatment Market Forecast: Breakup by Route of Administration (USD Million), 2023-2028
8. Global Psoriatic Arthritis Treatment Historical Market: Breakup by Region (USD Million), 2018-2022
9. Global Psoriatic Arthritis Treatment Market Forecast: Breakup by Region (USD Million), 2023-2028
10. North America Psoriatic Arthritis Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
11. North America Psoriatic Arthritis Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Europe Psoriatic Arthritis Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
13. Europe Psoriatic Arthritis Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Asia Pacific Psoriatic Arthritis Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
15. Asia Pacific Psoriatic Arthritis Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Latin America Psoriatic Arthritis Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
17. Latin America Psoriatic Arthritis Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Middle East and Africa Psoriatic Arthritis Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
19. Middle East and Africa Psoriatic Arthritis Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
20. Global Psoriatic Arthritis Treatment Market Structure
Key Questions Answered in the Report
In 2020, the global psoriatic arthritis treatment market attained a value of nearly USD 8.4 billion.
The market is projected to grow at a CAGR of 9.8% between 2021 and 2026.
The major drivers of the market include the increasing acceptance of medical therapy by patients suffering from moderate to serious psoriatic arthritis, new product launches, growing disease prevalence, and rising government initiatives.
The intensive research taking place to provide treatment to the patients suffering from psoriasis condition is the key industry trend propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading drug classes of psoriatic arthritis treatment in the industry are NSAIDs, DMARDs, and biologics, among others.
The significant product types in the market are prescription and OTC.
The major routes of administration of psoriatic arthritis treatment in the industry are topical, oral, and injectable.
The major players in the industry are AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., UCB SA, and AstraZeneca plc, among others.
Analyst Review
The global psoriatic arthritis treatment market attained a value of USD 8.4 billion in 2020, driven by the increasing acceptance of medical therapy by patients. Aided by the growing R&D activities, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 9.8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug class, the psoriatic arthritis treatment industry can be segmented into NSAIDs, DMARDs, biologics, and other. On the basis of product type, the psoriatic arthritis treatment market is divided into prescription, and OTC. The psoriatic arthritis treatment industry can be segregated based on administration route into topical, oral, and injectable. The major regional markets for psoriatic arthritis treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., Bristol-Myers Squibb Company, Celgene Corporation, Novartis International AG, Eli Lilly and Company, Pfizer Inc., UCB SA, AstraZeneca plc, and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER